AC3056

Thuốc Gốc

Small Molecule

AC3056 is a non-peptide antioxidant that acts as an inhibitor of vascular cell adhesion molecule expression originally developed by Aventis Pharmaceuticals. It as since been acquired by Amylin Pharmaceuticals and has completed phase I trials.

Dược Lực Học : Oral administration of AC3056 results in dose-dependent antioxidant activity and was well tolerated. In 2002, positive results were reported from a phase I trial. In the double-blind, placebo-controlled, crossover trial, 14 healthy subjects received an oral formulation of AC3056 in a dose-escalating manner. Results demonstrated dose-dependent increases in blood levels of AC3056, as well as dose-dependent increases in serum antioxidant activity. The drug was well tolerated with no safety concerns.

Dược Động Học :

▧ Absorption :
Absorbed following oral administration.

Chỉ Định : For the treatment of atherosclerosis and other conditions related to the obstruction of blood vessels.

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05230

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading